Home Product companies Röchling Medical and Trendlines Innovation Labs Join Forces to Bring Cutting-Edge Innovation...

Röchling Medical and Trendlines Innovation Labs Join Forces to Bring Cutting-Edge Innovation and Manufacturing Expertise to the Healthcare Industry

1
0

Posted: October 6, 2021 at 5:00 a.m. CDT|Update: 23 minutes ago

MANNHEIM, Germany and MISGAV, Israel, October 6, 2021 / PRNewswire / РR̦chling Medical, a division of the German R̦chling Group and a leading manufacturer in the healthcare industry, and Trendlines Innovation Labs, the innovation and R&D arm of The Trendlines Group (SGX: 42T) (OTCQX: TRNLY ), announced a collaboration agreement to provide a one-stop shop for innovation, development and manufacturing of medical devices.

R̦chling Medical is a renowned partner of leading pharmaceutical, biotechnology and medical companies around the world, providing complete manufacturing solutions and a wide range of high quality custom components and assemblies, including end-to-end OEM products. R̦chling Medical brings a proven track record to serving the life sciences and pharmaceutical industry. As a manufacturing partner, R̦chling Medical offers flexibility, responsiveness and traceability Рfrom start to finish.

Trendlines Innovation Labs is an innovation partner, inventing and investing with life science companies. Trendlines Innovation Labs brings extensive expertise in the invention and R&D of breakthrough medical products with an emphasis on early stage development. The strength of Trendlines Innovation Labs is its ability to invent new solutions and new products with speed and focus, which address critical unmet needs with the goal of improving the human condition.

The Collaboration Agreement builds on the strengths of each party and that by joining forces, the parties will expand and improve the value proposition and offering of comprehensive solutions for innovation, product development and manufacturing for the health sector, expanding their individual and joint efforts.

Dr Boris Fröhlich, President and CEO of Röchling Medical, said: “We are excited to be working with Trendlines Innovation Labs. This collaboration best meets the needs of our partners. We are amazed to have entered into this great partnership to support our partners in providing health care to people around the world. “

Nir Goldenberg, CEO of Trendlines Innovation Labs, added: “We are extremely excited about our collaboration with Röchling Medical. By joining forces, we will be able to provide a superior value proposition to our partners, as well as timely and quality delivery of innovation, product development, and manufacturing. By working together, we will significantly improve our common proposition, as well as the product offering of our partners. “

About the Röchling Group

The Röchling Group has shaped industry around the world for almost 200 years. The German company is transforming people’s lives every day with its personalized plastics: they reduce the weight of cars, secure drug packaging and improve industrial applications. The workforce of around 11,100 is located where Röchling customers are located – at 90 locations in 25 countries. The three divisions of the Industrial, Automotive and Medical Group generated joint annual sales of 2.039 billion euros in 2020. The medical division is developing innovative, reliable and personalized products, services and platform solutions for the healthcare sector. As a reliable partner, the medical division helps its customers achieve pioneering results in disease prevention and health restoration around the world.

About The Trendlines Group Ltd.

Trendlines invests and incubates innovation-based medical and food technologies to fulfill its mission to improve the human condition. As very active investors, Trendlines is involved in all aspects of its portfolio companies, from technology development to business creation. Trendlines shares are listed on the Singapore Stock Exchange (SGX: 42T) and in United States as American Depositary Receipt (ADR) on the OTCQX International (OTCQX: TRNLY).

Contact details:

Röchling Medical Waldachtal, Sebastien koller, Global R&D and Business Development Director, M [email protected], T +49 7486 181-315

Trendlines innovation labs, Nir Goldenberg, CEO, M [email protected], T +972 5233 53330

Show original content:

SOURCE The Trendlines group; Röchling Medical

The above press release has been provided courtesy of PRNewswire. The views, opinions and statements contained in the press release are not endorsed by Gray Media Group and do not necessarily state or reflect those of Gray Media Group, Inc.

LEAVE A REPLY

Please enter your comment!
Please enter your name here